Instructions for the use of L‐PRF in different clinical indications
Periodontology 2000 · 2025-02 · 97 (1) · 420-432
DOI: 10.1111/prd.12564 ↗At a glance
Übersichtsarbeit in Periodontology 2000, published online on 2024-05-27. Written by M Quirynen and 6 co-authors. Institution: Department of Oral Health Sciences, Katholieke Universiteit Leuven, Dentistry (Periodontology), University Hospitals Leuven, Leuven, Belgium. Major MEDLINE topics: Platelet-Rich Fibrin, Blood Platelets. Cited 36 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Autologous platelet concentrates (APCs) have demonstrated clear benefits across various clinical applications, including alveolar ridge preservation, guided tissue regeneration, guided bone regeneration, sinus floor elevation (both lateral window approach and transcrestal technique), endodontic surgery, the treatment of medication‐related osteonecrosis of the jaw bones, and periodontal plastic surgery. To ensure an optimal clinical outcome, clinicians must adhere strictly to the protocol to prepare the APCs and, especially follow evidence‐based surgical guidelines, often simple but crucial, to minimize the likelihood of errors. The majority of clinical trials reported on second‐generation APCs [the leukocyte‐ and platelet‐rich fibrin (L‐PRF) family, including its modifications (A‐PRF, A‐PRF+, CGF, T‐PRF, H‐PRF, etc.)]. These second‐generation APCs offer additional benefits compared to the first‐generation APCs, making them the preferred choice for the development of clinical recommendations. These recommendations have been formulated through a meticulous examination of the available clinical data and the clinical experience of the authors of this paper.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Oral Health Sciences, Katholieke Universiteit Leuven, Dentistry (Periodontology), University Hospitals Leuven, Leuven, Belgium.
- Department of Department of Stomatology, Unit of Periodontology, Santiago de Compostela University, Santiago de Compostela, Spain.
- Department of Periodontics and Oral Medicine, School of Dentistry, The University of Michigan, Michigan, USA.
- Centre for Oral Clinical Research, Institute of Dentistry, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL), London, UK.
- Center of Translational Medicine, Faculty of Medicine, Universidad de la Frontera, Temuco, Chile.
- Chairman of Center for Research in Regenerative Medicine and Tissue Engineering, Concepción, Chile.
ORCID profiles: M Quirynen, J Blanco, H-L Wang, N Donos, A Temmerman, A Castro, N Pinto
Cite
APA
Quirynen, M., Blanco, J., Wang, H. L., Donos, N., Temmerman, A., Castro, A., & Pinto, N. (2025). Instructions for the use of L‐PRF in different clinical indications. Periodontology 2000, 97(1), 420-432. https://doi.org/10.1111/prd.12564
Vancouver
Quirynen M, Blanco J, Wang HL, Donos N, Temmerman A, Castro A, et al. Instructions for the use of L‐PRF in different clinical indications. Periodontology 2000. 2025;97(1):420-432. doi:10.1111/prd.12564
BibTeX
@article{Quirynen2025,
author = {Quirynen, M and Blanco, J and Wang, H-L and Donos, N and Temmerman, A and Castro, A and Pinto, N},
title = {Instructions for the use of L‐PRF in different clinical indications},
journal = {Periodontology 2000},
year = {2025},
volume = {97},
number = {1},
pages = {420--432},
doi = {10.1111/prd.12564}
}
EUVIMED